04/01/2026
If you have MS, 2026 isn’t about a miracle drug.
It’s about better signal.
Relapses are late.
MRIs are infrequent.
And a lot of MS damage happens quietly, in between.
Blood biomarkers like neurofilament light chain and kappa free light chains are starting to change how decisions get made — not replacing MRI, but sharpening it.
The hard part isn’t the science.
It’s knowing how to raise this in clinic without sounding awkward, confrontational, or dismissed.
I’ve broken that down properly on Patreon — exact wording, when it makes sense to ask, and where biomarkers mislead if you over-interpret them.
Link in bio.
Neurology MSAdvocacy LivingWithMS